发明名称 Dosages for treatment with anti-ErbB2 antibodies
摘要 The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with anti-ErbB2 antibody.
申请公布号 US7371379(B2) 申请公布日期 2008.05.13
申请号 US20030600152 申请日期 2003.06.20
申请人 GENENTECH, INC. 发明人 BAUGHMAN SHARON A.;SHAK STEVEN
分类号 A61K39/395;A61K31/337;A61K31/704;A61K38/12;A61P15/00;A61P35/00;A61P35/02;A61P43/00;C07K16/32 主分类号 A61K39/395
代理机构 代理人
主权项
地址